Carbon nutrition of Escherichia coli in the mouse intestine.

Whole-genome expression profiling revealed Escherichia coli MG1655 genes induced by growth on mucus, conditions designed to mimic nutrient availability in the mammalian intestine. Most were nutritional genes corresponding to catabolic pathways for nutrients found in mucus. We knocked out several pathways and tested the relative fitness of the mutants for colonization of the mouse intestine in competition with their wild-type parent. We found that only mutations in sugar pathways affected colonization, not phospholipid and amino acid catabolism, not gluconeogenesis, not the tricarboxylic acid cycle, and not the pentose phosphate pathway. Gluconate appeared to be a major carbon source used by E. coli MG1655 to colonize, having an impact on both the initiation and maintenance stages. N-acetylglucosamine and N-acetylneuraminic acid appeared to be involved in initiation, but not maintenance. Glucuronate, mannose, fucose, and ribose appeared to be involved in maintenance, but not initiation. The in vitro order of preference for these seven sugars paralleled the relative impact of the corresponding metabolic lesions on colonization: gluconate > N-acetylglucosamine > N-acetylneuraminic acid = glucuronate > mannose > fucose > ribose. The results of this systematic analysis of nutrients used by E. coli MG1655 to colonize the mouse intestine are intriguing in light of the nutrient-niche hypothesis, which states that the ecological niches within the intestine are defined by nutrient availability. Because humans are presumably colonized with different commensal strains, differences in nutrient availability may provide an open niche for infecting E. coli pathogens in some individuals and a barrier to infection in others.

[1]  K. Krogfelt,et al.  An Escherichia coli MG1655 Lipopolysaccharide Deep-Rough Core Mutant Grows and Survives in Mouse Cecal Mucus but Fails To Colonize the Mouse Large Intestine , 2003, Infection and Immunity.

[2]  Dong-Eun Chang,et al.  Gene expression profiling of Escherichia coli growth transitions: an expanded stringent response model , 2002, Molecular microbiology.

[3]  T Conway,et al.  DNA array analysis in a Microsoft Windows environment. , 2002, BioTechniques.

[4]  A. Servin,et al.  Escherichia coli strains colonising the gastrointestinal tract protect germfree mice againstSalmonella typhimuriuminfection , 2001, Gut.

[5]  D. Relman,et al.  The meaning and impact of the human genome sequence for microbiology. , 2001, Trends in microbiology.

[6]  J. Lengeler,et al.  Pathways for the utilization of N‐acetyl‐galactosamine and galactosamine in Escherichia coli , 2000, Molecular microbiology.

[7]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Blattner,et al.  Functional Genomics: Expression Analysis ofEscherichia coli Growing on Minimal and Rich Media , 1999, Journal of bacteriology.

[9]  J. Zweier,et al.  Noninvasive measurement of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Conway,et al.  Sequence Analysis of the GntII (Subsidiary) System for Gluconate Metabolism Reveals a Novel Pathway for l-Idonic Acid Catabolism in Escherichia coli , 1998, Journal of bacteriology.

[11]  T. Conway,et al.  What’s for Dinner?: Entner-Doudoroff Metabolism inEscherichia coli , 1998, Journal of bacteriology.

[12]  J. Kaper,et al.  Escherichia coli 0157:H7 and other shiga toxin-producing E. coli strains , 1998 .

[13]  N. W. Davis,et al.  The complete genome sequence of Escherichia coli K-12. , 1997, Science.

[14]  A. Kalif.  Virulence mechanisms of bacterial pathogens , 1997 .

[15]  D. Laux,et al.  Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine , 1996, Infection and immunity.

[16]  M. Schembri,et al.  The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine , 1996, Infection and immunity.

[17]  T. R. Licht,et al.  Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice , 1995, Journal of bacteriology.

[18]  J. Roth,et al.  Virulence Mechanisms of Bacterial Pathogens , 1995 .

[19]  M. Hill,et al.  Role of gut bacteria in human toxicology and pharmacology. , 1995 .

[20]  T. Egli,et al.  Is Escherichia coli growing in glucose-limited chemostat culture able to utilize other sugars without lag? , 1995, Microbiology.

[21]  R. Kolter,et al.  Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine. , 1994, Microbial pathogenesis.

[22]  C. S. Kristensen,et al.  Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization , 1994, Infection and immunity.

[23]  K. Krogfelt,et al.  Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine. , 1993, Microbial pathogenesis.

[24]  A. Corfield,et al.  Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria , 1992, Infection and immunity.

[25]  D. van der Waaij,et al.  Determination of colonization resistance of the digestive tract by biotyping of Enterobacteriaceae , 1990, Epidemiology and Infection.

[26]  A. O’Brien,et al.  Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 , 1990, Infection and immunity.

[27]  S. Eykyn.  Microbiology , 1950, The Lancet.

[28]  G. Sims.  Micro‐organisms in Action: Concepts and Applications in Microbial Ecology , 1989 .

[29]  D. Laux,et al.  Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus , 1988, Infection and immunity.

[30]  R. Donaldson.  Microbial metabolism in the digestive tract: Edited by M. J. Hill. 254 pp. $93.50 (U.S.); $107.50 (elsewhere). CRC Press, Boca Raton, Florida, 1986 , 1987 .

[31]  R. Donaldson.  Microbial metabolism in the digestive tract , 1987 .

[32]  D. Laux,et al.  In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant , 1987, Infection and immunity.

[33]  M. Hill.  Microbial metabolism in the digestive tract , 2017 .

[34]  L. Hoskins,et al.  Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. , 1985, The Journal of clinical investigation.

[35]  V. Cabelli,et al.  Relationship between the mouse colonizing ability of a human fecal Escherichia coli strain and its ability to bind a specific mouse colonic mucous gel protein , 1983, Infection and immunity.

[36]  D. Tilman.  Resource competition and community structure. , 1983, Monographs in population biology.

[37]  L C Hoskins,et al.  Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. , 1981, The Journal of clinical investigation.

[38]  P. Taylor,et al.  Theoretical studies on the coexistence of competing species under continuous-flow conditions. , 1975, Canadian journal of microbiology.

[39]  M. P. Bryant.  Nutritional features and ecology of predominant anaerobic bacteria of the intestinal tract. , 1974, The American journal of clinical nutrition.

[40]  F. Neidhardt,et al.  Culture Medium for Enterobacteria , 1974, Journal of bacteriology.

[41]  and D G Fraenkel,et al.  Carbohydrate Metabolism in Bacteria , 1973 .

[42]  R. Freter.  Parameters Affecting the Association of Vibrios with the Intestinal Surface in Experimental Cholera , 1972, Infection and immunity.

[43]  M. Bohnhoff,et al.  CHANGES IN THE MOUSE'S ENTERIC MICROFLORA ASSOCIATED WITH ENHANCED SUSCEPTIBILITY TO SALMONELLA INFECTION FOLLOWING STREPTOMYCIN TREATMENT. , 1963, The Journal of infectious diseases.